Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

New hair regrowth therapies show promise but need more research.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Careful management of steroid use is crucial in pregnant women with bullous pemphigoid to avoid complications like Cushing syndrome.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Skin maturation in Dezhou donkey foals involves better barrier function, hair growth, and less collagen production.

A new treatment using microneedles with black phosphorus and laser helps regrow hair effectively and safely.

Electrospun 3D nanofibrous materials show promise for bone regeneration in orthopaedics.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Advances in RNA research and skin models offer hope for better skin healing without scarring.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Baricitinib is a promising treatment for alopecia areata.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Certain genes are linked to the risk of developing Alopecia Areata.

The nail immune system is similar to hair but different from skin, with fewer immune markers.